Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required) (345087)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Apr 19, 2023 (Letter of inquiry)

Later deadlines: May 19, 2023 (Full proposal)

Grant amount: Up to US $700,000

Funding uses: Research, Training / Capacity Building

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization.

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to participate in the NIAID Autoimmunity Centers of Excellence (ACE), a cooperative network intended to improve the understanding, prevention, and treatment of autoimmune diseases (www.autoimmunitycenters.org). The ACE program was founded on the premise that collaborations among basic and clinical scientists can accelerate both fundamental and applied research. The ACE combines Basic and Clinical research programs. This FOA solicits applications for the Clinical research program; a companion FOA solicits applications for the Basic research program. Members of the Clinical research program will conduct innovative studies of human autoimmunity within Clinical and Collaborative Projects. Members of the Basic and Clinical ACE will work together to design and conduct studies of autoimmune disease pathogenesis and mechanisms of action of immune-modulating interventions being tested in ACE clinical trials.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.